Duran, Deib Lohr D.
HRN: 14-55-65 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
09/22/2022
AMPICILLIN 1GM + SULBACTAM 500MG (VIAL)
09/22/2022
09/29/2022
IVT
480mg
Q6H
UTI
Waiting Final Action
Indication: Empiric Type of Infection: Urinary Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes